FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial - Rojo, F; Taylor, CR; Barrios, C; Torrecillas, L; Ruiz-Borrego, M; Perez-Buira, S; Bines, J; Guerrero-Zotano, A; Garcia-Saenz, JA; Torres, R; de la Haba-rodriguez, J; Ayala, F; et al. (Clinical Cancer Research, 2025)